$RNGE Cashflow Statement | Understand Stock

$RNGE

$0.75 -$0.05 (6.75%) Close

$RNGE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2020 12 months to Mar 31, 2021
Cash flows from operating activities:
Net income (loss)
Less: Loss from discontinued operations
Loss from continuing operations
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Gain on bargain purchase
Net loss on asset disposals of discontinued operations
Gain on disposition of business
Gain on disposition of asset retirement obligations
Gain on sale of fixed assets
Fair value of vested stock options
Operating lease expense
Gain on extinguishment of liabilities, net of cash received of $450,000
Accrual of interest added to note payable
Goodwill Impairment
Goodwill impairment of discontinued operations
Fixed asset impairment
Depreciation of property and equipment
Depreciation of discontinued operations
Amortization of long-term intangible assets
Accretion of asset retirement obligations
Changes in operating assets and liabilities:
Accounts receivable
Accounts receivable from discontinued operations
Unbilled receivables from discontinued operations
Contract assets from discontinued operations
Forgiveness of PPP loan
Prepaid expenses and other current assets
Deposits
Accounts payable and accrued liabilities
Operating lease liability

Net cash used in operating activities - continuing operations
Accounts payable
Accounts payable from discontinued operations
Accrued expenses
Accrued expenses from discontinued operations
Cash paid for asset retirement obligations
Deposits
Deposits from discontinued operations

Net cash provided by (used in) operating activities

Cash flows from investing activities:
Cash acquired in acquisition of Range Environmental Resources
Equipment purchases
Capital expenditures
Cash paid for equipment purchases
Cash paid in consideration for Collins Building acquisition
Long-term debt issued for Collins Building acquisition
Cash paid for acquisition of land
Net proceeds from sale of assets
Cash paid for acquisition of Range Environmental Resources
Proceeds from asset sales
Long-term deposits received
Net proceeds from sale of assets from discontinued operations
Net insurance proceeds from casualty loss from discontinued operations
Net proceeds from disposition of Graphium Biosciences
Net cash provided by investing activities

Cash provided by financing activities:
Proceeds from PPP loan
Issuance of shares for cash
Proceeds from notes issued in acquisition of Collins Building
Proceeds from long-term debt
Repayment of long-term debt
Payoff of SBA disaster loan
Repayment of line of credit
Net cash provided by/ (used in) financing activities

Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents - beginning of period
Cash and cash equivalents - end of period
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest expense
Income taxes
Shares issued for acquisition
Long-term debt from Range Reclamation Entities acquisition
Forgiveness of PPP loan
Supplemental schedule of non-cash investing and financing activities:
Line of credit converted to term bank debt
Reduction in accounts receivable as part of FOLA transaction
Acquisition of land related to asset retirement obligation
Debt forgiveness related to equipment surrender
Debt forgiveness related to Collins Building asset disposal
Debt reduction transferred to deficiency claim
Initial recording of asset retirement cost and asset retirement obligation
Reduction of bargain purchase gain for noncontrolling equity interest

Comments